Most Patients With Cancer-Associated Dermatomyositis Have Antibodies to Nuclear Matrix Protein NXP-2 or Transcription Intermediary Factor 1γ

OBJECTIVE: Since dermatomyositis (DM) is associated with an increased risk of malignancy, accurate identification of patients likely to harbor cancers is important. Using immunoprecipitations from radiolabeled cell lysates, several groups recently showed that anti–transcription intermediary factor 1...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Fiorentino, David F., Chung, Lorinda S., Christopher-Stine, Lisa, Zaba, Lisa, Li, Shufeng, Mammen, Andrew L., Rosen, Antony, Casciola-Rosen, Livia
Formato: Artigo
Idioma:Inglês
Publicado: 2013
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4073292/
https://ncbi.nlm.nih.gov/pubmed/24037894
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/art.38093
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares